A Study of Coformulated Favezelimab/Pembrolizumab (MK-4280A) Versus Physician's Choice Chemotherapy in PD-(L)1-refractory, Relapsed or Refractory Classical Hodgkin Lymphoma (MK-4280A-008)

UZ Leuven-Hematology ( Site 0101), Leuven

Western Health-Sunshine & Footscray Hospitals-Cancer Services-Cancer Research ( Site 0002), St Albans

The Townsville Hospital ( Site 0006), Townsville

Royal Adelaide Hospital ( Site 0005), Adelaide

Université Catholique de Louvain-Namur - Centre Hospitalier Universitaire Dinant-Godinne - Site Godi, Namur

Royal Perth Hospital-Haematology ( Site 0004), Perth

Ospedale Regionale Bellinzona e Valli-IOSI ( Site 1600), Bellinzona

Roswell Park Cancer Institute ( Site 2220), Buffalo

CHUAC-Complejo Hospitalario Universitario A Coruña ( Site 1812), A Coruña

AHN West Penn Hospital ( Site 2213), Pittsburgh

UPMC Hillman Cancer Center ( Site 2205), Pittsburgh

University of Maryland-Greenebaum Comprehensive Cancer Center ( Site 2210), Baltimore

Johns Hopkins University-The Sidney Kimmel Comprehensive Cancer Center ( Site 2206), Baltimore

Skånes Universitetssjukhus Lund ( Site 1901), Lund

Hospital Universitario 12 de Octubre-Hemathology and hemotherapy ( Site 1810), Madrid

Hospital Universitario Virgen de la Victoria ( Site 1808), Málaga

Institut Universitaire du Cancer Toulouse - Oncopole - CHU de TOULOUSE ( Site 0706), Toulouse

Moffitt Cancer Center ( Site 2200), Tampa

Mega Medipol-Hematology ( Site 2005), Stanbul

Hospital Insular de Gran Canaria-Oncology ( Site 1807), Las Palmas de Gran Canaria

Centre Hospitalier Universitaire de Rennes - Hôpital Pontchaillou-haematology ( Site 0707), Rennes

Ege Universitesi Hastanesi ( Site 2001), Izmir

Hospital Universitario de Salamanca - Complejo Asistencial U-Servicio de Hematologia ( Site 1801), Salamanca

Hospital Universitario Marqués de Valdecilla ( Site 1805), Santander

University of Kentucky Chandler Medical Center ( Site 2201), Lexington

Kocaeli Üniversitesi-Hematology ( Site 2009), Kocaeli

University Hospitals Cleveland Medical Center ( Site 2214), Cleveland

Cleveland Clinic-Taussig Cancer Center ( Site 2203), Cleveland

Universitaetsklinikum Essen ( Site 0807), Essen

University of Michigan ( Site 2215), Ann Arbor

Universitätsklinikum Münster - Albert Schweitzer Campus ( Site 0806), Münster

Pusan National University Hospital-Internal Medicine ( Site 1704), Busan

Cancer and Hematology Centers of Western Michigan ( Site 2222), Grand Rapids

Universitaetsklinikum Koeln-Klinik I für Innere Medizin ( Site 0801), Cologne

CENTRE LEON BERARD-Medical oncology ( Site 0703), Lyon

Klinikum Stuttgart - Katharinenhospital ( Site 0804), Stuttgart

Unidad Médica Onco-hematológica ( Site 2507), Puebla City

The University of Arizona Cancer Center - North Campus ( Site 2216), Tucson

Centre Hospitalier Universitaire de Limoges - Hôpital Dupuytren ( Site 0704), Limoges

Universitaetsklinikum Ulm-Department of Internal Medicine III ( Site 0805), Ulm

UCLA Hematology/Oncology - Santa Monica ( Site 2208), Los Angeles

Lundquist Institute for Biomedical Innovation at Harbor-UCLA-Hematology and Medical Oncology ( Site, Torrance

Institut Curie - site Saint-Cloud ( Site 0708), Saint-Cloud

HENRI MONDOR HOSPITAL ( Site 0702), Créteil

Fred Hutchinson Cancer Center ( Site 2212), Seattle

Beijing Hospital ( Site 0514), Beijing

Peking University Third Hospital-Hematology ( Site 0519), Beijing

The First Hospital of Jilin University-Hematology ( Site 0516), Changchun

Fudan University Shanghai Cancer Center ( Site 0520), Shanghai

Anhui Provincial Cancer Hospital ( Site 0501), Hefei

Tianjin Medical University Cancer Institute & Hospital-lymphoma ( Site 0506), Tianjin

Zhejiang Cancer Hospital ( Site 0510), Hangzhou

Ningbo First Hospital ( Site 0518), Ningbo

The First Affiliated hospital of Xiamen University ( Site 0512), Xiamen

Xiangya Hospital Central South University ( Site 0513), Changsha

Hunan Cancer Hospital ( Site 0503), Changsha

Union Hospital Tongji Medical College Huazhong University of Science and Technology ( Site 0509), Wuhan

Henan Cancer Hospital ( Site 0515), Zhengzhou

Sun Yat-sen University Cancer Center ( Site 0500), Guangzhou

West China Hospital of Sichuan University-Head and Neck Oncology ( Site 0502), Chengdu

Rambam Health Care Campus ( Site 1004), Haifa

Carmel Hospital ( Site 1007), Haifa

Rabin Medical Center-Hemato-Oncology ( Site 1001), Petah Tikva

Sheba Medical Center-Hemato Oncology ( Site 1005), Ramat Gan

Sourasky Medical Center ( Site 1002), Tel Aviv

FALP-UIDO ( Site 0400), Santiago

Clínica Inmunocel ( Site 0407), Santiago

Hadassah Medical Center-Hemato-Oncology ( Site 1000), Jerusalem

Fundação Pio XII - Hospital de Câncer de Barretos ( Site 0202), Barretos

Rutgers Cancer Institute of New Jersey ( Site 2217), New Brunswick

Hospital Aleman-oncohematologic diseases ( Site 2302), Buenos Aires

Fundacion Centro Oncologico de Integración Regional-Medical Oncology ( Site 2301), Mendoza

Hospital Paulistano-Americas Oncologia ( Site 0207), São Paulo

Cross Cancer Institute ( Site 0313), Edmonton

Princess Margaret Cancer Centre ( Site 0310), Toronto

Jewish General Hospital ( Site 0309), Montreal

McGill University Health Centre ( Site 0314), Montreal

Fakultní nemocnice Brno Bohunice-Interni hematologicka a onkologicka klinika ( Site 0901), Brno

Fakultni nemocnice Hradec Kralove-IV. interni hematologicka klinika ( Site 0902), Hradec Králové

Vseobecna fakultni nemocnice v Praze-I. Interní klinika - klinika hematologie ( Site 0903), Prague

Universitaetsklinikum Carl Gustav Carus Dresden-University Cancer Center Early Clinical Trial Unit (, Dresden

Universitätsklinikum Leipzig ( Site 0803), Leipzig

Centro de Infusion Superare ( Site 2503), Mexico City

Szpital Specjalistyczny im. Ludwika Rydygiera w Krakowie-Oncology Department ( Site 1406), Krakow

Uniwersytecki Szpital Kliniczny im. Jana Mikulicza-Radeckieg-Klinika Hematologii, Nowotworów Krwi i, Wroclaw

Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - P-Kilinka Onkologii I Hematologii ( Site, Warsaw

Uniwersyteckie Centrum Kliniczne-Klinika Hematologii i Transplantologii ( Site 1402), Gdansk

Swietokrzyskie Centrum Onkologii, Samodzielny Publiczny Zakl-Klinika Hematologii i Transplantacji S, Kielce

Seoul National University Hospital ( Site 1701), Seoul

Severance Hospital, Yonsei University Health System-Medical oncology ( Site 1702), Seoul

Asan Medical Center-Department of Oncology ( Site 1703), Seoul

Samsung Medical Center ( Site 1700), Seoul

Hospital Universitari Vall d'Hebron ( Site 1803), Barcelona

Hospital General Universitario de Alicante ( Site 1806), Alicante

Akademiska sjukhuset-Blod- och tumörsjukdomar ( Site 1900), Uppsala

Ankara Universitesi Tip Fakultesi Hastanesi-hematology ( Site 2000), Ankara

Hacettepe Universite Hastaneleri-Department of Hematology ( Site 2006), Ankara

Antalya Egitim ve Arastırma Hastanesi ( Site 2011), Antalya

Derriford Hospital ( Site 2107), Plymouth

The Beatson West of Scotland Cancer Centre ( Site 2110), Glasgow

St Bartholomew's Hospital-Centre for Experimental Cancer Medicine ( Site 2105), London

GenesisCare - Oxford ( Site 2104), Oxford

St James's University Hospital ( Site 2109), Leeds

Leicester Royal Infirmary ( Site 2100), Leicester

Clatterbridge Cancer Centre - Liverpool-Heamatology ( Site 2108), Liverpool